The global bioengineering technology market, worth US$294.5 billion in 2025, is projected to reach a CAGR of US$835.5 billion by 2034. North America and Europe are leading, and the Asia-Pacific region is emerging rapidly. The main factors include the demand for personalized medicine and sustainable agriculture, but challenges include high costs and regulatory concerns.
Bioengineering Technology Market
Bioengineering Technology Market
Dublin, June 30, 2025 (Globe Newswire) – “Bioengineering Technology Market Size, Share, Trends, Analytics, Forecast 2025-2034 | Global Industry Growth, Competitive Landscapes, Opportunities and Challenges” report has been added to the offer of ResearchAndmarkets.com.
The global bioengineering technology market is valued at US$294.5 billion in 2025. Additionally, the market is expected to grow at a CAGR of 12.3%, reaching USD 83.55 billion by 2034.
The bioengineering technology market includes a variety of innovations aimed at promoting healthcare, agriculture, environmental sustainability and industrial processes. Bioengineering integrates biological principles and engineering techniques to develop cutting-edge solutions in tissue engineering, synthetic biology, biochemistry, genetic engineering and more.
These technologies contribute to the production of biopharmaceuticals, improving agricultural productivity, addressing environmental challenges, and strengthening the production of bio-based materials and energy sources. The rapid growth of the market is driven by increased demand for personalized medicine, sustainable agricultural practices and environmentally friendly production processes.
Technological advancements and interdisciplinary collaboration are driving the market forward. The rise of CRISPR-CAS9 and other gene editing tools will revolutionize genetic engineering and enable accurate modification of organisms for therapeutic and industrial applications. Meanwhile, advances in bioprinting and tissue scaffolding are opening up new possibilities for regenerative medicine, organ transplantation, and drug discovery. Furthermore, the convergence of bioengineering with data analysis, artificial intelligence and high-throughput screening technology has accelerated the pace of innovation and has made the timeline of more efficient workflows and product development.
Regionally, North America and Europe lead the bioengineering technology market, supported by strong research funding, a well-established biotechnology industry and a favorable regulatory environment. The Asia-Pacific region has emerged as a fast-growing region due to increased investment in biotechnology research, expansion of healthcare infrastructure, and increased demand for agricultural and industrial bioengineering solutions. As global challenges such as climate change, food security and public health continue to intensify, bioengineering technologies are becoming pivotal in delivering sustainable, scalable and impactful solutions across multiple sectors.
What you receive
Global Bioengineering Technology Market Size and Growth Forecast (CAGR), 2024-2034
The impact of recent changes in geopolitical, economic and trade policies on demand and supply chains for bioengineering technologies.
Market size, share and outlook for bioengineering technology across 2025-2034 in five regions and 27 countries.
Market size, CAGR, and market share for key products, applications, and end-user industries, 2025-2034.
Short-term and long-term bioengineering technology market trends, drivers, controls, and opportunities.
Porter’s five force analysis, technology development in the bioengineering technology market, and bioengineering technology supply chain analysis.
Profiles of the five leading companies in the industry – Overview, Key Strategy, Finance and Products.
Newest Bioengineering Technology Market News and Development.
Important attributes:
Report attributes
detail
Number of pages
150
Forecast period
2025-2034
Estimated Market Value (USD) for 2025
$294.5 billion
Forecast Market Value (USD) by 2034
$83.55 billion
Combined annual growth rate
12.3%
Covered areas
global
trend
Rapid advances in gene editing technology, particularly CRISPR, are driving innovation in medicine and agriculture.
Integrating bioengineering with AI and data analysis for accelerated research and product development.
Expansion of bio-based materials and biofuels to address environmental sustainability and reduce dependence on fossil resources.
driver
The growing demand for personalized medicine and advanced treatment solutions.
It focuses on sustainable agricultural practices and bio-based industrial processes.
Strong investments from governments, research institutions and private companies in bioengineering R&D.
assignment
The high costs and technical complexity associated with the development and scaling of bioengineering technologies.
Regulatory and ethical considerations, particularly regarding genetic modifications and synthetic biology.
Limited infrastructure and expertise in certain regions slows adoption of advanced bioengineering applications.
The company was introduced
Pfizer Inc.
Johnson & Johnson
Roche Holding AG
Novartis AG
Bristol Myers Squibb Company
Thermo Fisher Scientific
Abbott Institute
Astrazeneca plc
Medtronic plc
Gilead Sciences Inc.
Amgen Inc.
Novo Nordisk a/s
Moderna Inc.
Becton Dickinson (BD)
Regeneron Pharmaceuticals Inc.
Biogen Inc.
Vertex Pharmaceuticals Inc.
Agilent Technology
Lonza Group Ltd.
Intuitive surgery
Illumina Inc
Bio-Rad Laboratories
Ginkgo Bioworks
Verve Therapeutics Inc.
CRISPR Therapeutics
Market segmentation
Depending on the product
By technology
By application
By geography
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, and the rest of Europe)
Asia Pacific (China, India, Japan, Australia, Vietnam, and other APACs)
Middle East and Africa (Middle East, Africa)
South and Central America (Argentina, Brazil, remaining SCA)
For more information about this report, please visit://www.researchandmarkets.com/r/ko965u
About ResearchAndmarkets.com ResearchAndmarkets.com is the world’s leading source of international market research reports and market data. Provides the latest data on international and regional markets, major industries, top companies, new products and latest trends.
Attachments
Contact: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com est office hours for call call 1-917-300-0470 for can free call call for gmt office hours call +353-1-416-8900
